Clinical trial
A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
NCT01234467 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- August 31, 2016
- Enrollment
- 23 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse large b-cell lymphoma, diffuse large-cell lymphoma, lymphoma, lymphoma, diffuse large-cell